researchers and participants throughout all phases of clinical research and is tailored to meet the regulatory requirements of more than 100 territories, ensuring smooth and compliant trial ...

Phase 1 results of a next-generation treatment targeting KRAS G12C, the cause of lung cancer, colon cancer, and pancreatic ...

Close collaboration between researchers and clinicians at Mayo is what makes the steps of translation — from discovery to the ...

We look forward to supporting innovation in the life science industry by continuing to deliver effective risk transfer ...